Table 1.
Af alone | TS group | p-value | |
---|---|---|---|
(n = 35) | (n = 38) | ||
Age, years (mean ± SE) | 74.7 ± 1.53 | 75.2 ± 1.66 | n.s. |
Male sex, n (%) | 24 (74%) | 23 (61%) | n.s. |
NIHSS | 4.74 ± 0.92 | 3.76 ± 0.44 | n.s. |
Body mass index (mean ± SE) | 21.3 ± 0.59 | 21.2 ± 0.67 | n.s. |
Risk factors | |||
Hypertension | 17 (49%) | 17 (45%) | n.s. |
Diabetes | 11 (31%) | 9 (24%) | n.s. |
Hyperlipidemia | 8 (23%) | 10 (26%) | n.s. |
Smoking* | 13 (42%) | 12 (35%) | n.s. |
Preventive therapy for infarction | |||
Anticoagulant therapy | 8 (23%) | 2 (5%) | <0.05 |
Antiplatelet therapy | 2 (6%) | 5 (14%) | n.s. |
Anticoagulant therapy after stroke | 31 (89%) | 31 (82%) | n.s. |
Maximum size of lesion < 15 mm | 23 (66%) | 20 (53%) | n.s. |
Infarcts on multiple vascular territories | 17 (49%) | 28 (74%) | <0.05 |
D-dimer value (μg/mL) | |||
On admission | 1.14 ± 0.14 | 8.45 ± 1.79 | <0.0001 |
During days 7–28† | 0.48 ± 0.12 | 11.20 ± 2.77 | <0.0001 |
Af, atrial fibrillation; others, other diseases; SE, standard error; n.s., not significant.
Smoking histories of nine patients (five with Af, four with cancer) could not be determined.
D-dimer values between days 7 and 28 after stroke onset in 28 patients (11 with Af, 17 with cancer) could not be determined.